OpenVSafe by OpenVAERS
Search V-safe

LZL-18669-50462

3 vaccinations 3 coded responses 6 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
935 / CA
Registered
2021-02-03
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2020-12-31
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-17
    Dose 2 — Pfizer-BioNTech
  3. 2021-02-03
    Registered in v-safe
  4. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  5. 2021-02-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  6. 2021-04-19
    Survey response — 3 months, dose 2
    MedDRA: Menstruation delayed — Feeling: Good
    Free text: No period for 2 months
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-08-30
    Dose 3 — Pfizer-BioNTech
  8. 2021-09-28
    Survey response — day 28, dose 3
    MedDRA: Chest discomfort — Feeling: Good · Be unable to work or attend school
    Free text: Chest pressure
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-03-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  10. 2022-09-01
    Survey response — 12 months, dose 3
    MedDRA: Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Heart palpitations.
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-09-01
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  12. 2022-09-02

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Pfizer-BioNTech
22021-01-17Pfizer-BioNTech
32021-08-30Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — 3 months, dose 2

2021-04-19

Symptoms: No period for 2 months

Release 9 — day 28, dose 3

2021-09-28

Symptoms: Chest pressure

Release 12 — 12 months, dose 3

2022-09-01

Symptoms: Heart palpitations.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest discomfort · · ✓
SDMenstruation delayed ✓ ✓ ✓
SDPalpitations · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…